How should I titrate a nicardipine infusion (stock concentration 10 mg in 10 mL) for a patient with severe hypertension (200/100 mmHg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nicardipine Infusion Titration Protocol

Start nicardipine at 5 mg/h and titrate upward by 2.5 mg/h every 15-30 minutes until target blood pressure is achieved (typically <160/100 mmHg for severe hypertension), with a usual range of 5-15 mg/h, then decrease to 3 mg/h for maintenance. 111

Stock Concentration Conversion

Your stock concentration is 10 mg in 10 mL = 1 mg/mL. This is more concentrated than standard premixed bags (0.1-0.2 mg/mL), so you'll need to dilute it or carefully calculate infusion rates:

  • 5 mg/h = 5 mL/h of your stock solution
  • 7.5 mg/h = 7.5 mL/h of your stock solution
  • 10 mg/h = 10 mL/h of your stock solution
  • 12.5 mg/h = 12.5 mL/h of your stock solution
  • 15 mg/h = 15 mL/h of your stock solution
  • 3 mg/h (maintenance) = 3 mL/h of your stock solution

Titration Algorithm

Initial Dosing

  • Start: 5 mg/h (5 mL/h with your concentration)
  • Onset of action: 5-15 minutes 1
  • Duration: 30-40 minutes 1

Titration Steps

  1. Check blood pressure every 5-15 minutes during titration
  2. If target BP not reached after 15-30 minutes, increase by 2.5 mg/h (2.5 mL/h)
  3. Continue increasing by 2.5 mg/h increments every 15-30 minutes
  4. Maximum dose: 15 mg/h (15 mL/h) 111
  5. Once target BP achieved, decrease to 3 mg/h (3 mL/h) for maintenance 111

Target Blood Pressure

  • For severe hypertension (200/100 mmHg): Reduce to <160/100 mmHg initially
  • Avoid dropping BP more than 15-25% in the first 24 hours to prevent end-organ hypoperfusion 1
  • The mean time to therapeutic response is approximately 77 minutes for severe hypertension 2

Critical Monitoring Requirements

Monitor continuously:

  • Blood pressure every 5 minutes during active titration
  • Heart rate (watch for reflex tachycardia) 12
  • Avoid systemic hypotension, especially in stroke patients 2

Important Caveats

Contraindications

  • Liver failure is an absolute contraindication 111
  • Use caution in portal hypertension (can increase hepatic venous pressure gradient) 2

Common Adverse Effects

  • Headache and reflex tachycardia are most common 111
  • Monitor for symptomatic hypotension 2
  • Tachycardia may require beta-blocker co-administration in cardiac patients 2

IV Site Management

  • Change infusion site every 12 hours to minimize venous irritation 2
  • Use large peripheral or central veins, not small hand/wrist veins 2
  • Avoid arterial administration 2

Special Populations

Renal impairment: Lower systemic clearance occurs; titrate more cautiously 2

Hepatic impairment: Use lower doses and monitor closely 2

Pre-eclampsia/eclampsia: Nicardipine is safe and effective; combine with magnesium sulfate 113. Monitor fetal heart rate continuously 1

Practical Dosing Example for Your Patient (200/100 mmHg)

  1. Start: 5 mL/h (5 mg/h)
  2. After 15 min: Check BP. If still >160/100, increase to 7.5 mL/h (7.5 mg/h)
  3. After 15 min: Check BP. If still elevated, increase to 10 mL/h (10 mg/h)
  4. Continue until BP <160/100 mmHg
  5. Once controlled: Decrease to 3 mL/h (3 mg/h) for maintenance
  6. Transition: Begin oral antihypertensives and wean nicardipine over several hours

The average maintenance dose in clinical trials was 8 mg/h for severe hypertension 2, but guidelines recommend decreasing to 3 mg/h once control is achieved 111.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.